Menu
Of the 10 million cases, approximately 60% are viral and 40% are bacterial.
Clinical differential diagnosis is extremely challenging as the signs and symptoms of disease are virtually indistinguishable. Both etiologies result in moderate to severe inflammation of the conjunctiva, the mucous membrane that covers the front of the eye and lines the inside of the eyelids.
Corneal opacity occurs in 20-50% of viral conjunctivitis cases, and can lead to scarring or clouding of the cornea. Significantly, this may result in long-term visual impairment and premature/chronic dry eye.
Signs and symptoms of infectious conjunctivitis include eye pain, redness, swelling and discharge, which cause significant discomfort and embarrassment.
Currently it takes 2-3 weeks to resolve without treatment. OKG-0303 will significantly shorten the infection and associated symptoms.
Virus causes conjunctivitis via replication in infected cells
The anti-viral preferentially enters virally infected cells and inhibits viral replication
The anti-viral inhibits viral replication and the ocular decongestant reduces redness & discharge
The anti-viral inhibits viral replication and the ocular decongestant reduces redness & discharge
United States
Okogen, Inc.
8400 Belleview Drive, Suite 125
Plano, Texas 75024
USA
Australia
Okogen Pty Ltd
Level 9, 31 Queen St
Melbourne, VIC 3000
AUS